Datavault AI Inc. (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc. (NASDAQ: MEDS), extending its PharmacyChain blockchain technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications. The amended agreement, announced via a press release, is designed to support patient-controlled health data access, monetization, and real-world asset tokenization across pharmacy, medical, laboratory, and wearable device environments. This expansion leverages a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring.
Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies said the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
Datavault AI is leading the way in AI-driven data experiences, valuation, and monetization of assets in the Web 3.0 environment. Its cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Sciences divisions. The Data Science division leverages Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization. The company's platform serves multiple industries, including healthcare, through its Information Data Exchange, which enables Digital Twins and the licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata.
This expansion into commercial healthcare is significant as it targets the growing demand for patient-controlled health data, allowing individuals to potentially monetize their own health information. The integration of blockchain technology aims to enhance data security and transparency in medical records, laboratory results, and wearable device data. The move could impact the healthcare industry by providing new models for data transactions and patient engagement, while also creating opportunities for Datavault AI to tap into the global health and wellness market.
For more information, view the full press release at https://ibn.fm/vBAxH.
